SCHEMBL24865482

SCHEMBL24865482

CC1CCCCN1c1ccc(Nc2ccc3c(c2)n(C)c(=O)n3C)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 3/20 0.44
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
SMN1; SMN2 Q16637 6/20 0.42
ALDH1A1 P00352 3/20 0.42
TP53 P04637 2/20 0.42
HSD17B10 Q99714 1/20 0.42
BRPF1 P55201 4/20 0.40
BRD4 O60885 2/20 0.40
LMNA P02545 2/20 0.39
HTT P42858 2/20 0.39
GAA P10253 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
BRD1 O95696 2/20 0.38
BCL6 P41182 2/20 0.38
PKM P14618 2/20 0.38
ALOX12 P18054 1/20 0.38
XIAP P98170 1/20 0.38
BIRC2 Q13490 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30336512 0.82 SMN1; SMN2 (0.48) TRIM24SMN1; SMN2ALDH1A1TP53HSD17B10
SCHEMBL24865584 0.82 SMN1; SMN2 (0.48) TRIM24SMN1; SMN2ALDH1A1TP53HSD17B10
SCHEMBL30336935 0.81 SMN1; SMN2 (0.49) TRIM24SMN1; SMN2ALDH1A1TP53HSD17B10
SCHEMBL24865236 0.81 SMN1; SMN2 (0.49) TRIM24SMN1; SMN2ALDH1A1TP53HSD17B10
SCHEMBL24865209 0.79 SMN1; SMN2 (0.46) TRIM24SMN1; SMN2ALDH1A1TP53HSD17B10
SCHEMBL30336497 0.79 SMN1; SMN2 (0.46) TRIM24SMN1; SMN2ALDH1A1TP53HSD17B10
SCHEMBL24865656 0.77 SMN1; SMN2 (0.45) TRIM24SMN1; SMN2ALDH1A1TP53HSD17B10
SCHEMBL24865363 0.76 TRIM24 (0.70) TRIM24SMN1; SMN2ALDH1A1TP53HSD17B10
SCHEMBL24865245 0.76 MKNK1 (0.42) MAOAMAOBALDH1A1BRD4PIK3CA
SCHEMBL30336087 0.76 MKNK1 (0.42) MAOAMAOBALDH1A1BRD4PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2024-10-03 US disclosed
CN-117999259-A Iron death modulators, their preparation and use 维泰瑞隆有限公司 2024-05-07 CN disclosed
WO-2023280296-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-01-12 WO disclosed
WO-2023280296-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF AIFM2, GPX1, GPX4 TRIM24 4393/4885MAOA 2331/4885MAOB 1722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.